MUNC-CD34

N/A

Report date: 2026/05/23 20:00:57

Base Information

Drug NameMUNC-CD34

Drug Alias NameMUNC-CD34

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapyCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Lentiviral vector

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsLymphohistiocytosis, Hemophagocytic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesAssistance Publique Hopitaux De Paris

China Registration ClassN/A

Develop Information

Active CompaniesAssistance Publique Hopitaux De Paris

Inactive CompaniesN/A

Active IndicationsLymphohistiocytosis, Hemophagocytic

Inactive IndicationsN/A

Other Information

ATC CodeN/A